Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07892937

CIC101-02-LT is a Long-term Follow-up Study of Participants Treated With TRTP-101 and Will Evaluate the Long-term Safety and Efficacy of TRTP-101.

Conditions: Atrophic Scar

Sex: All

Ages: 19 Years – N/A

Healthy volunteers: Yes

Enrollment: 31

Sponsor: CellinCells

Location: Samsung Medical Center Seoul

Summary

CIC101-02-LT is a long-term follow-up study of participants treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.

Eligibility Criteria

Inclusion Criteria: * Received TRTP-101 in clinical trial CIC101-02 * Provided written informed consent to participate in this study Exclusion Criteria: * Judged to face significant health or safety risks by participating in this long-term follow-up study * Judged to be unable to continuously participate in or complete this long-term follow-up study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07892937). StuddyBuddy aggregates publicly available trial information.